A biotech holds a $250M IPO, stoking flames of hope for industry watchers


It's a rarity for 2023: A biotech company just went public in a $250 million IPO, at a $2.7 billion valuation.

Previous U.S. Bank hiring dozens of bankers as it targets health care practices
Next https://crej.com/news/149223/?utm_source=rss&utm_medium=rss&utm_campaign=149223